Theator Secures $3M Seed Funding to Advance AI-Powered Clinical Data Platform for Precision Surgery

VCBeat (WeChat Official Account: vcbeat) learned from foreign media that on April 21, U.S. local time, medical technology company Theator completed a $3 million seed funding round. The proceeds from this round will be used to develop an AI-powered medical data platform to help medical teams deliver healthcare services efficiently and precisely.

It is reported that this round of financing was led by StageOne Ventures, with iAngels participating as a co-investor.

Theator, a medical technology company founded in 2018 and headquartered in Israel, is currently developing Minutes, a SaaS platform designed to provide surgeons with AI-powered clinical assistance tools.

Currently, there are numerous cases of surgical failure caused by inaccurate medical data. Failed surgeries can lead to sequelae in patients and even endanger their lives. Such inaccuracies often stem from the subjective nature of surgical practice, where attending physicians must independently determine the appropriate medical approach. Factors such as preoperative preparations and hospital medical equipment can influence physicians’ subjective judgments, thereby increasing the risk of surgical failure.

The Minutes platform leverages machine learning and provides precise medical imaging to assist physicians in scientifically determining the most appropriate surgical approach. Furthermore, its database houses thousands of similar medical cases; even if the system cannot immediately recommend an optimal treatment plan, the information provided enables the medical team to analyze the patient’s condition and reduce the risk of surgical failure.

Furthermore, the Minutes platform provides video technology to facilitate smoother surgical procedures. This technology records the entire surgical process and offers the medical team a comprehensive view of the patient’s affected area. By studying various surgical videos and analyzing video imagery of patient pathology, medical teams can enhance their work efficiency and reduce unnecessary surgeries.

“We firmly believe that visualization and machine learning technologies will transform the current landscape of the surgical industry,” said Yoav Samet, Managing Partner at StageOne Ventures. “Assisting medical teams in determining treatment plans is just the beginning; we will continue to advance research in the field of AI-driven healthcare. In the future, artificial intelligence is expected to perform surgeries on behalf of physicians, leveraging digitalization and visualization technologies to help patients recover their health.”

Mor Assia, Founding Partner and Co-CEO of iAngels, stated, “Artificial intelligence is permeating an increasing number of fields. We must keep pace with the times, leverage science and technology to drive continuous innovation in healthcare, and cultivate our own market. We believe that AI-driven medical technology will disrupt traditional healthcare models and deliver superior medical services to patients.”

StageOne Ventures is a venture capital firm dedicated to investing in healthcare startups within the digital technology sector, primarily focusing on early- and late-stage companies. To date, it has completed 54 investments. With an experienced management team, StageOne Ventures not only provides financial support to startups but also leverages market resources to help entrepreneurs develop and manage their companies.

iAngels, founded in 2013, is an early-stage venture capital firm that leverages data analytics and market research to identify investment opportunities. Primarily focusing on early-stage companies, it has completed 53 investments to date.

(Compiled by Liu Yujing)